Why doesn't scientific research evolve as a solution to problems in Brazil? The answers to this question go through several layers and one of them is the importance of the intersection between the public sector and the private sector in building partnerships in both the development and regulation of processes. Who highlights this is Marina Domenech, CEO of Intrials Clinical Research, founder of SAIL for Health and vice-president of the Brazilian Association of Representative Organizations for Clinical Research (ABRACRO). She also states that having Biotimize and a #CDMO in Brazil means being able to scale research and retain technology within the country, avoiding the diaspora of knowledge to reach full innovation. This is a fundamental step towards strengthening the health ecosystem, allowing Brazil to become increasingly self-sufficient in scientific development and expanding the population's access to quality healthcare. #FromPaperToThePeople is a series of content about the importance of infrastructure for scaling research, allowing it to get off the ground and reach those in need. #Sthorm #FindTheOthers #Biotechnology #Biotimize #People #Research #FutureofHealthCare
Thank you for your support! Together we are stronger!
It is essential to invest in disruptive projects that keep minds and innovative initiatives in Brazil. Great insights from Marina Domenech, our CEO, on the launch of Biotimize's CDMO!
Biotimize is an incredible initiative that will allow important developments for the Brazilian health chain. We are glad to contribute to such a disruptive project! 🚀